Complement Deficiency

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

CSL Behring
CSL BehringIL - Bradley
1 program
Immunological diagnosis testsN/A
Octapharma
OctapharmaAustria - Vienna
1 program
Immunological diagnosis testsN/A1 trial
Active Trials
NCT02972281Terminated120Est. Mar 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OctapharmaImmunological diagnosis tests

Clinical Trials (1)

Total enrollment: 120 patients across 1 trials

NCT02972281OctapharmaImmunological diagnosis tests

Systematic Search for Primary Immunodeficiency in Adults With Infections

Start: Mar 2015Est. completion: Mar 2020120 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space